Comparison of the prognostic effect of sarcopenia on atezolizumab plus bevacizumab and lenvatinib therapy in hepatocellular carcinoma patients
Author:
Affiliation:
1. Department of Surgery and Science, Graduate School of Medical Sciences Kyushu University Fukuoka Japan
Publisher
Wiley
Subject
Gastroenterology,Hepatology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgh3.12777
Reference31 articles.
1. Hepatocellular carcinoma
2. Impact of Immune Response on Outcomes in Hepatocellular Carcinoma: Association With Vascular Formation
3. Medical therapy of HCC
4. Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
5. Sarcopenia
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Prognostic impact of body composition in hepatocellular carcinoma patients with immunotherapy;Annals of Medicine;2024-08-27
2. Association of serum lactate dehydrogenase with prognosis and tumor metabolism in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab therapy;Surgery Today;2024-08-04
3. The Negative Impact of Sarcopenia on Hepatocellular Carcinoma Treatment Outcomes;Cancers;2024-06-24
4. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in advanced gastrointestinal cancer immunotherapy: evidence from published studies and a Chinese single center cohort;Clinical Cancer Bulletin;2024-04-24
5. The clinical significance of sarcopenia in patients with hepatocellular carcinoma treated with lenvatinib and PD-1 inhibitors;Frontiers in Immunology;2024-04-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3